Health News Updates: Keyword News: [diabetes]
Posted in New diabetes treatments @ February 18, 2009
Human Genome Sciences Inc., which licensed its experimental treatment to GlaxoSmithKline PLC five years ago, will get a $9 million milestone payment as clinical trials advance. ... LONDON, Feb 17 (Reuters) - GlaxoSmithKline said on Tuesday that it was starting large-scale phase III trials for its diabetes drug Syncria. The drug is one of a new generation of diabetes drugs called GLP-1 agonists that have come under the spotlight after the only drug of its kind on ...
indications of diabetes
Diabetes Symptoms Are you worried you are a diabetic? Are you diabetic and concerned about any new or different symptoms? Are you looking for a diabetes test? Please feel free to post your questions, concerns or related information in ...
Tags: diabetes, drug, diabetic, glaxosmithkline, trials